ASPHF
Price
$9.32
Change
-$0.78 (-7.72%)
Updated
Sep 17 closing price
Capitalization
3.26B
Intraday Buy/Sell Signals
CMVLF
Price
$5.04
Change
+$2.44 (+93.85%)
Updated
Oct 16 closing price
Capitalization
474.94M
Intraday Buy/Sell Signals
Interact to see
Advertisement

ASPHF vs CMVLF

Header iconASPHF vs CMVLF Comparison
Open Charts ASPHF vs CMVLFBanner chart's image
ASCENTAGE PHARMA GROUP
Price$9.32
Change-$0.78 (-7.72%)
Volume$3.2K
Capitalization3.26B
Cellectis Romainville
Price$5.04
Change+$2.44 (+93.85%)
Volume$100
Capitalization474.94M
ASPHF vs CMVLF Comparison Chart in %
ASPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASPHF vs. CMVLF commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASPHF is a Hold and CMVLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (ASPHF: $9.32 vs. CMVLF: $5.04)
Brand notoriety: ASPHF and CMVLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASPHF: 127% vs. CMVLF: 100%
Market capitalization -- ASPHF: $3.26B vs. CMVLF: $474.94M
ASPHF [@Biotechnology] is valued at $3.26B. CMVLF’s [@Biotechnology] market capitalization is $474.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASPHF’s FA Score shows that 0 FA rating(s) are green whileCMVLF’s FA Score has 0 green FA rating(s).

  • ASPHF’s FA Score: 0 green, 5 red.
  • CMVLF’s FA Score: 0 green, 5 red.
According to our system of comparison, CMVLF is a better buy in the long-term than ASPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASPHF’s TA Score shows that 2 TA indicator(s) are bullish while CMVLF’s TA Score has 5 bullish TA indicator(s).

  • ASPHF’s TA Score: 2 bullish, 3 bearish.
  • CMVLF’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, CMVLF is a better buy in the short-term than ASPHF.

Price Growth

ASPHF (@Biotechnology) experienced а 0.00% price change this week, while CMVLF (@Biotechnology) price change was +93.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASPHF($3.26B) has a higher market cap than CMVLF($475M). ASPHF (246.468) and CMVLF (236.000) have similar YTD gains . CMVLF has higher annual earnings (EBITDA): -30.25M vs. ASPHF (-1.09B). ASPHF has more cash in the bank: 1.66B vs. CMVLF (196M). CMVLF has less debt than ASPHF: CMVLF (94.8M) vs ASPHF (1.72B). ASPHF has higher revenues than CMVLF: ASPHF (391M) vs CMVLF (56.3M).
ASPHFCMVLFASPHF / CMVLF
Capitalization3.26B475M686%
EBITDA-1.09B-30.25M3,588%
Gain YTD246.468236.000104%
P/E RatioN/AN/A-
Revenue391M56.3M694%
Total Cash1.66B196M847%
Total Debt1.72B94.8M1,810%
FUNDAMENTALS RATINGS
CMVLF: Fundamental Ratings
CMVLF
OUTLOOK RATING
1..100
37
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ASPHFCMVLF
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
59%
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
33%
Momentum
ODDS (%)
Bullish Trend 3 days ago
43%
Bullish Trend 3 days ago
40%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
52%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
11%
Bullish Trend 3 days ago
28%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
33%
Bullish Trend 3 days ago
26%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
50%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 3 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
ASPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WMLIX35.83N/A
N/A
Wilmington Large-Cap Strategy Instl
DCCRX28.19N/A
N/A
Macquarie Small Cap Core R
RGGYX27.40N/A
N/A
Victory RS Global Y
SVXYX70.47N/A
N/A
Smead International Value Y
FAPHX13.83N/A
N/A
Fidelity Healthy Future

ASPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASPHF has been loosely correlated with CGEN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ASPHF jumps, then CGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASPHF
1D Price
Change %
ASPHF100%
N/A
CGEN - ASPHF
41%
Loosely correlated
-3.85%
CLLS - ASPHF
34%
Loosely correlated
-11.95%
CMVLF - ASPHF
34%
Loosely correlated
N/A
NURPF - ASPHF
30%
Poorly correlated
N/A
ALDX - ASPHF
27%
Poorly correlated
-2.41%
More

CMVLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMVLF has been closely correlated with CLLS. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if CMVLF jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMVLF
1D Price
Change %
CMVLF100%
N/A
CLLS - CMVLF
78%
Closely correlated
-11.95%
ABCZF - CMVLF
59%
Loosely correlated
N/A
SLN - CMVLF
41%
Loosely correlated
-1.37%
ALDX - CMVLF
39%
Loosely correlated
-2.41%
CLGN - CMVLF
37%
Loosely correlated
-0.64%
More